Centaurus Biopharma has a total of 418 patents globally, out of which 238 have been granted. Of these 418 patents, more than 64% patents are active. China is where Centaurus Biopharma has filed the maximum number of patents, followed by United States of America and Europe. Parallelly, China seems to be the main focused R&D centre and also is the origin country of Centaurus Biopharma.
Centaurus Biopharma was founded in the year 2006. The Company is an R&D company which specializes in the research and development of antioxidants. These new nitrone-related therapeutics are expected to fight diseases, which are strongly influenced by oxidative stress.
Do read about some of the most popular patents of Centaurus Biopharma which have been covered by us in this article and also you can find Centaurus Biopharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Centaurus Biopharma patent portfolio.
How many patents does Centaurus Biopharma have?
Centaurus Biopharma has a total of 418 patents globally. These patents belong to 60 unique patent families. Out of 418 patents, 269 patents are active.
How Many Patents did Centaurus Biopharma File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Centaurus Biopharma Applications Filed | Centaurus Biopharma Patents Granted |
2023 | – | 22 |
2022 | – | 35 |
2021 | 3 | 51 |
2020 | 7 | 48 |
2019 | 11 | 22 |
2018 | 64 | 18 |
2017 | 110 | 18 |
2016 | 79 | 8 |
2015 | 38 | 7 |
2014 | 27 | 3 |
2013 | 15 | 2 |
2012 | 35 | 4 |
How many Centaurus Biopharma patents are Alive/Dead?
How Many Patents did Centaurus Biopharma File in Different Countries?
Countries in which Centaurus Biopharma Filed Patents
Country | Patents |
China | 46 |
United States of America | 39 |
Europe | 35 |
Japan | 30 |
Germany | 25 |
Austria | 23 |
Korea (South) | 22 |
Canada | 21 |
Australia | 21 |
Hong Kong (S.A.R.) | 19 |
Russian Federation | 14 |
Spain | 13 |
Taiwan | 10 |
India | 10 |
Denmark | 6 |
Macao | 6 |
Hungary | 5 |
Italy | 5 |
Brazil | 5 |
Portugal | 4 |
South Africa | 3 |
Norway | 3 |
Poland | 3 |
Mexico | 2 |
Eurasian Patent Organization | 1 |
Finland | 1 |
Singapore | 1 |
Israel | 1 |
Where are Research Centres of Centaurus Biopharma Patents Located?
10 Best Centaurus Biopharma Patents
WO2014082598A1 is the most popular patent in the Centaurus Biopharma portfolio. It has received 71 citations so far from companies like Beigene, Ltd., Janssen Pharmaceutica Nv and Redx Pharma Plc.
Below is the list of 10 most cited patents of Centaurus Biopharma:
Publication Number | Citation Count |
WO2014082598A1 | 71 |
CN103848810A | 43 |
CN104513229A | 34 |
WO2017016513A1 | 34 |
WO2013097773A1 | 34 |
WO2012059041A1 | 31 |
WO2017133681A1 | 28 |
CN102584830A | 27 |
WO2012092880A1 | 27 |
WO2018077246A1 | 26 |
What Percentage of Centaurus Biopharma US Patent Applications were Granted?
Centaurus Biopharma (Excluding its subsidiaries) has filed 35 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 31 have been granted leading to a grant rate of 91.18%.
Below are the key stats of Centaurus Biopharma patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Centaurus Biopharma?
Law Firm | Total Applications | Success Rate |
Kilpatrick Townsend & Stockton Llp | 15 | 86.67% |
Fish & Richardson P C | 4 | 100.00% |
Maschoff Brennan | 2 | 100.00% |
Nixon Peabody Llp | 2 | 100.00% |
Renner Otto Boisselle & Sklar | 2 | 100.00% |
Seed Intellectual Property Law Group Llp | 2 | 100.00% |
Weaver Austin Villeneuve & Sampson Llp | 2 | 100.00% |
Cantor Colburn Llp | 1 | 0.00% |
Fox Rothschild Llp | 1 | 100.00% |
Leason Ellis Llp | 1 | 100.00% |
What are Centaurus Biopharma key innovation segments?
What Technologies are Covered by Centaurus Biopharma?
The chart below distributes patents filed by Centaurus Biopharma in different countries on the basis of the technology protected in patents. It also represents the markets where Centaurus Biopharma thinks it’s important to protect particular technology inventions.
R&D Focus: How has Centaurus Biopharma search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!